WBSCR17 Antibody Blocking peptide

Putative polypeptide N-acetylgalactosaminyltransferase-like protein 3, Polypeptide GalNAc transferase-like protein 3, GalNAc-T-like protein 3, pp-GaNTase-like protein 3, Protein-UDP acetylgalactosaminyltransferase-like protein 3, UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3, Williams-Beuren syndrome chromosomal region 17 protein, WBSCR17, GALNTL3

The synthetic peptide sequence was selected from the C-term region of WBSCR17. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.